BioHarvest Sciences Inc.
BHST
$6.75
-$0.08-1.17%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 6.48% | 8.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.48% | 8.33% | |||
| Cost of Revenue | 1.98% | 5.02% | |||
| Gross Profit | 9.52% | 10.69% | |||
| SG&A Expenses | -9.09% | 9.77% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.32% | 7.84% | |||
| Operating Income | 49.31% | -5.58% | |||
| Income Before Tax | 39.37% | -75.70% | |||
| Income Tax Expenses | 61.54% | 2.63% | |||
| Earnings from Continuing Operations | 38.41% | -74.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 38.41% | -74.51% | |||
| EBIT | 49.31% | -5.58% | |||
| EBITDA | 62.00% | -6.67% | |||
| EPS Basic | 38.77% | -74.57% | |||
| Normalized Basic EPS | 39.71% | -75.66% | |||
| EPS Diluted | 38.77% | -74.57% | |||
| Normalized Diluted EPS | 39.71% | -75.66% | |||
| Average Basic Shares Outstanding | 0.56% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.56% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||